Adlai Nortye Ltd. American Depositary Shares (ANL) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $835.48M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | KY | CEO | Yang Lu |
| IPO Date | 2023-09-29 | CAGR | — |
| Employees | 109 | Website | www.adlainortye.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $152.06M | P/E | -11.32 | Forward P/E | -53.48 | PEG | — |
| P/S | 60.73 | P/B | 1.67 | P/CF | -6.16 | P/FCF | -20.51 |
| Sales | $19.68M | Sales 1Y | 203.24% | Sales 3Y | — | Sales 5Y | — |
| EPS | $-1.39 | EPS 1Y | -72.32% | EPS 3Y | — | EPS 5Y | — |
| Sales QoQ | — | EPS QoQ | — | Sales QoQ Avg | 107.29% | EPS QoQ Avg | -32.02% |
| Gross Margin | 100% | Operating Margin | -113.28% | Profit Margin | -114.48% | ROCE | -9.99% |
| ROA | -9% | ROE | -22% | Altman Z Score | 12.96 | Piotroski Score | 2 |
| Current Ratio | 9.55 | Quick Ratio | 9.55 | Cash Ratio | 5.26 | Op. CF Ratio | -0.3 |
| Debt/Equity | 0.12 | Debt/Assets | 0.11 | Lt Debt/Equity | 0.04 | Lt Debt/Cap. | 0.03 |
| Intrst Cov. | — | Inventory Turnover | — | Asset Turnover | 0.08 | Receivables Turnover | 74.55 |
| Enterprise Value | $152.06M | P/E Ratio | -11.32 |
| Forward P/E | -53.48 | PEG Ratio | — |
| P/S Ratio | 60.73 | P/B Ratio | 1.67 |
| P/CF Ratio | -6.16 | P/FCF Ratio | -20.51 |
| EPS | $-1.39 | EPS Growth 1Y | -72.32% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 203.24% | Gross Margin | 100% |
| Operating Margin | -113.28% | Profit Margin | -114.48% |
| ROE | -22% | ROA | -9% |
| ROCE | -9.99% | Current Ratio | 9.55 |
| Quick Ratio | 9.55 | Cash Ratio | 5.26 |
| Debt/Equity | 0.12 | Interest Coverage | — |
| Altman Z Score | 12.96 | Piotroski Score | 2 |
View Adlai Nortye Ltd. American Depositary Shares financial charts →
Adlai Nortye Ltd. American Depositary Shares (ANL) valuation & financials
Adlai Nortye Ltd. American Depositary Shares (ANL) has a market capitalization of $835.48M and trades at a price-to-earnings ratio of -11.3. It operates in the Healthcare sector (Biotechnology).
Adlai Nortye Ltd. American Depositary Shares's revenue grew +203.2% over the last year.
Adlai Nortye Ltd. American Depositary Shares's next earnings report is scheduled for March 3, 2027 (provider scheduled date); analysts estimate EPS of $-0.13. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)
Adlai Nortye Ltd. American Depositary Shares revenue & earnings charts →